To investigate the impact of cyclooxygenase-2 ( COX-2 ) inhibitor with - adrenoceptor blocker ( - blocker ) for men with benign prostatic hyperplasia ( BPH ) and lower urinary tract symptoms ( LUTS ) for detecting prostate cancer in men with elevated prostate specific antigen ( PSA ) .